z-logo
open-access-imgOpen Access
Impact of Intravitreal Ranibizumab Therapy on Vision Outcomes in Diabetic Macular Edema Patients: A Meta-Analysis
Author(s) -
Manuel Falcão
Publication year - 2019
Publication title -
ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.639
H-Index - 60
eISSN - 1423-0267
pISSN - 0030-3755
DOI - 10.1159/000505070
Subject(s) - ranibizumab , medicine , diabetic macular edema , ophthalmology , diabetic retinopathy , randomized controlled trial , visual acuity , macular edema , bevacizumab , diabetes mellitus , endocrinology , chemotherapy
Evaluation of the impact of the injection frequency of ranibizumab on best-corrected visual acuity (BCVA) outcomes in patients with diabetic macular edema (DME).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here